ACT-AEC (Accelerating Clinical Trials – Accélérer les Essais Cliniques) Canada was established to facilitate, optimize, and accelerate the conduct, implementation, and result translation from high-quality, high-impact randomized controlled trials to improve health in Canada and around the world.
- Connecting hundreds of researchers from 28 networks, 11 trial units, patient-partners, the biotechnology industry, government, and experts in research ethics review processes, contracts, insurance, regulatory processes, patient engagement, clinical trials training, communications, knowledge mobilization – from Nova Scotia to British Columbia and Nunavut.
- Maximizing research impact and knowledge mobilization – following best practices in patient-oriented research and integrated knowledge translation, leveraging national and international contacts.
- Advancing equitable access to trials for all Canadians – no matter where they live, inclusive of gender, ethnicity, and socioeconomic status – following the principles of equity, diversity, and inclusion in clinical trials such that the knowledge gained is applicable to all those affected.
- Building clinical trial capacity – providing trial units with the knowledge, skills, and experience to conduct large-scale trials. We will streamline administrative processes (for example, ethics reviews, contracts, and protocols) to accelerate timelines and reduce costs.